We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Nothing but net

11 July 2018 By Robert Cyran

Agreeing to freeze the price of treatments takes the U.S. firm out of the president’s unpleasant spotlight, but an increase may still be enacted by the end of the year. The sector’s opacity and complexity means posted prices have only a vague relationship to what consumers pay.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)